Signs and symptoms of Transthyretin amyloid cardiomyopathy (ATTR-CM)

SIGNS AND SYMPTOMS OF ATTR-CM

Because of the impact of transthyretin amyloid cardiomyopathy (ATTR-CM) on the heart, the disease often presents with symptoms of heart failure such as fatigue, shortness of breath and peripheral oedema (swelling in the lower legs). Other symptoms related to the build-up of amyloid fibrils throughout the body may also occur.^1,2

For people at a high risk of heart failure and showing any of these symptoms, it is important that they talk to their doctor or cardiologist. These signs and symptoms can also occur due to other conditions and they don’t necessarily suggest ATTR-CM. Further consultations and tests are essential to establish a diagnosis of ATTR-CM.

FURTHER INFORMATION FOR HEALTHCARE PROFESSIONALS

DETECT

References

Witteles RM et al. JACC Heart Fail 2019;7(8):709–16.
Donnelly J and Hanna M. Cleve Clin J Med 2017;84(12 Suppl 3):12–26.
Rapezzi C et al. Heart Fail Rev 2015;20:117–24.
Narotsky DL et al. Can J Cardiol 2016;32:1166.e1–e10.
AlJaroudi WA et al. J Nucl Cardiol 2014;21:271–83.
Brunjes DL et al. J Card Fail 2016;22:996–1003.
González-López E et al. Eur Heart J 2015;36:2585–94.
Borlaug BA and Paulus WJ. Eur Heart J 2011;2:670–79.
Siddiqi OK et al. Trends Cardiovasc Med 2018;28:10–21.
Castaño A et al. Heart Fail Rev 2015;20:163–78.
Quarta CC et al. Circulation 2014;129:1840–49.
Carroll JD et al. Am J Cardiol 1982;49:9–13.
Ruberg FL and Berk JL. Circulation 2012;126:1286–300.
Maurer MS et al. J Am Coll Cardiol 2016;68:161–72.
Cyrille NB et al. Am J Cardiol 2014;114:1089–93.
Connors LH et al. Circulation 2016;133:282–90.
Ng B et al. Arch Intern Med 2005;165:1425–9.
Grogan M et al. Heart 2017;103:1065–72.
Nakagawa M et al. Amyloid 2016;23:58–63.
Westermark P et al. Ups J Med Sci 2014;119:223–8.
Papoutsidakis N et al. J Card Fail 2018;24:131–3.
Coelho T et al. Curr Med Res Opin 2013;29:63–76.
Phelan D et al. Heart 2012;98:1442–8.
Geller HI et al. JAMA 2017;318:962–3.
Givens RC et al. Aging Health 2013;9:229–35.
Ruberg FL et al. J Am Coll Cardiol 2019;73:2872–91.
Castaño A et al. Eur Heart J 2017;38:2879–87.
Rubin J et al. Amyloid 2017;24:226–30.